HOME >> MEDICINE >> NEWS
Columbia U receives $16.9M award to study origin and health effects of arsenic in ground water

ater has been associated with the development of skin, bladder, kidney and lung cancers as well as non-carcinogenic effects such as diabetes, peripheral neuropathy and cardiovascular diseases, public health intervention strategies to reduce arsenic exposure are critical."

The latest Superfund grant also includes a component studying the effects of environmental arsenic on children's health. While exposure to arsenic has long been known to have neurological consequences in the occupational setting, to date there have been limited well-controlled studies of children or of the potential effects of chronic exposure to arsenic in groundwater used for drinking and cooking.

Since the early 1990s, when the epidemic of arsenic poisoning began to emerge in Bangladesh, India, and other countries in South Asia, it has been estimated that as many as 100 million people worldwide regularly drink or cook with well water with arsenic concentrations greater than 10 micrograms per liter (g/L) or 10 parts per billion (ppb), the World Health Organization's maximum exposure level. Until the early 1970s, people in Bangladesh generally did not drink well water, but rather relied on microbially-contaminated surface water, which caused a host of infectious diseases, particularly fatal diarrheal diseases in young children. Ironically, the arsenic crisis arose as a result of the well-intentioned efforts of non-governmental organizations, which installed millions of tube wells throughout the country in an attempt to shift communities away from the consumption of microbially-contaminated surface water, not realizing that the ground water was naturally enriched with arsenic. "I am delighted that we have been given the opportunity to continue our efforts to link our growing understanding of the fundamental mechanisms of arsenic release to groundwater with more effective mitigation in the U.S. and in Bangladesh," said Alexander van Geen, Doherty Senior Research Scientists at Lamont-
'"/>

Contact: stephanie berger
sb2247@columbia.edu
212-305-4372
Columbia University's Mailman School of Public Health
2-Aug-2006


Page: 1 2 3

Related medicine news :

1. Columbia dentists to improve oral health in sub-Saharan Africa
2. NY-Presbyterian Hospital/Columbia University Medical Center doctors present at 2007 AUA Meeting
3. Columbia study examines ADHDs role in smoking
4. Columbia scientists present research findings at AHA Scientific Sessions
5. Columbia pediatricians, Anne Gershon and Richard Polin, awarded top honors
6. Columbia researchers restore memory lost in mice with Alzheimers
7. Research at University of British Columbia receives historical recognition
8. Columbia receives up to $15 million from Spinal Muscular Atrophy Foundation
9. Columbia study suggests benefits of Zyflamend in the early treatment of prostate cancer
10. Columbia study shows how doctors may manage blood glucose levels during heart surgery
11. Columbia study shows elderly with diabetes at increased risk for falling

Post Your Comments:
(Date:8/3/2015)... ... August 03, 2015 , ... A July 13 article from The Daily ... to Release Natural Painkiller That Can Last 'For Five Weeks'" discusses the use ... the new study showed that harvesting stem cell-rich bone marrow from the hip, known ...
(Date:8/3/2015)... ... ... Illinois Health & Science (IHS) has completed the purchase of IBA Molecular North ... NA’s cyclotron sites and research and development facilities. , “We are excited ... a large manufacturing hub in Noblesville, Indiana,” said Ken Smithmier, President and CEO of ...
(Date:8/3/2015)... ... August 03, 2015 , ... Hub International Insurance ... Williams has joined its growing California employee benefits division. Mr. Williams will ... his clients. Mr. Williams will be joining the newly integrated Northern California employee ...
(Date:8/3/2015)... (PRWEB) , ... August 03, 2015 , ... ... Government Programs, with accountability for overall performance of the company’s Medicare and Federal ... focus of Cambia’s strategy to deliver better health for members. In this role, ...
(Date:8/3/2015)... ... August 03, 2015 , ... ... provider of medical information, risk management and investigative services, has introduced a ... toward focused, expert information solutions that improve business outcomes for its customers. ...
Breaking Medicine News(10 mins):Health News:Los Angeles Spine Surgeon Gives Insight into How Stem Cells Can Relieve Back Pain 2Health News:Los Angeles Spine Surgeon Gives Insight into How Stem Cells Can Relieve Back Pain 3Health News:Illinois Health & Science Expands Nuclear Medicine Footprint With Purchase of IBA Molecular North America, Inc. 2Health News:HUB International Insurance Services Announces Joe Williams Has Joined its Northern California Employee Benefits Division 2Health News:Cambia Health Solutions Names Scott Powers President of Government Programs 2Health News:EMSI Announces New Branding: Powerful Information. Improved Outcomes. 2
(Date:8/3/2015)... -- Encision Inc. (PK:ECIA), a medical device company owning patented ... minimally invasive surgery, today announced financial results for its ... The Company posted quarterly net revenue of ... thousand, or $(0.02) per share. These results compare to ... of $202 thousand, or $(0.02) per share, in the ...
(Date:8/2/2015)... , Aug. 3, 2015  Isis Pharmaceuticals, Inc. ... a strategic collaboration to discover and develop antisense ... new collaboration builds on a broad existing relationship ... approach in these therapeutic areas using novel RNA-targeted ... use of its antisense technology to diseases of ...
(Date:7/31/2015)... N.C. , July 31, 2015  In today,s ... customers who are increasingly mobile, increasingly connected, and increasingly ... growing variety of customer interaction channels and tools is ... including social media. According to research ... over the counter (OTC) segment in a call center ...
Breaking Medicine Technology:Encision Reports First Quarter Fiscal Year 2016 Results 2Encision Reports First Quarter Fiscal Year 2016 Results 3Encision Reports First Quarter Fiscal Year 2016 Results 4Encision Reports First Quarter Fiscal Year 2016 Results 5AstraZeneca and Isis Pharmaceuticals to Discover and Develop Antisense Drugs for Cardiovascular, Metabolic and Renal Diseases 2AstraZeneca and Isis Pharmaceuticals to Discover and Develop Antisense Drugs for Cardiovascular, Metabolic and Renal Diseases 3AstraZeneca and Isis Pharmaceuticals to Discover and Develop Antisense Drugs for Cardiovascular, Metabolic and Renal Diseases 4Best Practices in Building World-Class Consumer & Over-the-Counter Call Centers 2
Cached News: